Chiara M. Cassani

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 06, 2026

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Reconsidering PARP inhibitor-radiotherapy combinations in the stereotactic era.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 03, 2026

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.

Journal: Lancet (London, England)

Published: February 10, 2026

Beyond the placebo effect: a systematic review and a network meta-analysis of treatment strategies for vulvodynia.

Beyond the placebo effect: a systematic review and a network meta-analysis of treatment strategies for vulvodynia.

Journal: BMC women's health

Published: February 06, 2026

Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.

Clinical and molecular heterogeneity in advanced-stage POLE-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations.

Journal: Frontiers in oncology

Published: January 31, 2026

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Journal: Tumori

Published: December 15, 2025

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.

Journal: Journal of medical cases

Published: November 26, 2025

Treatment of Uncomplicated Vulvovaginal Candidiasis: Topical or Oral Drugs? Single-Day or Multiple-Day Therapy? A Network Meta-analysis of Randomized Trials.

Treatment of Uncomplicated Vulvovaginal Candidiasis: Topical or Oral Drugs? Single-Day or Multiple-Day Therapy? A Network Meta-analysis of Randomized Trials.

Journal: Obstetrical & gynecological survey

Published: October 20, 2025

A meta-umbrella review of risk factors for vulvodynia: evidence from demographic, psychosocial, and biomedical domains.

A meta-umbrella review of risk factors for vulvodynia: evidence from demographic, psychosocial, and biomedical domains.

Journal: The journal of sexual medicine

Published: September 23, 2025

Does the abdominal entry method in laparoscopy really matter? A network meta-analysis of rare events in randomized trials.

Does the abdominal entry method in laparoscopy really matter? A network meta-analysis of rare events in randomized trials.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: September 22, 2025

Network meta-analysis of tocolytics in preterm labor: Establishing an evidence-based treatment hierarchy.

Network meta-analysis of tocolytics in preterm labor: Establishing an evidence-based treatment hierarchy.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: August 09, 2025

Quality of radiation shapes survival, invasiveness, and migration in ovarian cancer cell lines with different molecular profiles and varying alpha/beta ratios: an in vitro study on behalf of the Multicenter Italian Trials in Ovarian Cancer (MITO) group.

Quality of radiation shapes survival, invasiveness, and migration in ovarian cancer cell lines with different molecular profiles and varying alpha/beta ratios: an in vitro study on behalf of the Multicenter Italian Trials in Ovarian Cancer (MITO) group.

Journal: International journal of radiation biology

Published: August 06, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026